Dae Beom Kwon

Title: Dae Beom Kwon: Innovator in Immunoglobulin-Binding Proteins

Introduction

Dae Beom Kwon is a notable inventor based in Gyeongsangnam-do, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of immunoglobulin-binding proteins. His innovative work has led to advancements that enhance the stability and efficiency of antibody purification processes.

Latest Patents

Dae Beom Kwon holds a patent for a "Mutated immunoglobulin-binding protein having increased alkaline tolerance." This invention relates to a mutated immunoglobulin-binding protein that exhibits increased chemical stability at alkaline pH values compared to its parental molecule. The patent highlights the specific mutations made to the A-domain of Staphylococcal protein A, which contribute to its enhanced alkaline tolerance. This innovation is crucial for providing a more effective antibody-purifying ligand and matrix, which can withstand multiple alkaline cleaning cycles.

Career Highlights

Dae Beom Kwon is associated with Amicogen, Inc., a company that focuses on biopharmaceuticals and enzyme technology. His work at Amicogen has allowed him to apply his expertise in protein engineering to real-world applications, contributing to the company's mission of advancing biotechnological solutions.

Collaborations

Dae Beom Kwon has collaborated with notable colleagues, including Yong Chul Shin and Zhe Piao. These collaborations have fostered a productive environment for innovation and have led to further advancements in their respective fields.

Conclusion

Dae Beom Kwon's contributions to the field of immunoglobulin-binding proteins demonstrate his commitment to innovation and excellence in biotechnology. His patented work not only enhances the stability of antibody purification processes but also showcases the potential for future advancements in this area.